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Background: Among long-term care (LTC) residents, we explored the association between anemia status and
hemoglobin (Hb) level with Activities of Daily Living (ADL) functioning and health-related quality of life (HRQOL).
Methods: Data were derived from the AnalytiCare database, containing laboratory and Minimum Data Set (MDS)
reports for 27 LTC facilities in Colorado. Study timeframe was 1/1/07-9/15/08. Patients were selected based on:
residence in LTC >90 days, Hb and serum creatinine value within 90 days of the earliest non-admission (index)
MDS. From the index MDS, the method of 1) Carpenter et al. [BMC Geriatrics 6:7(2006)] was used to derive a
summary measure of ADL performance (the MDS-ADL score) and 2) Wodchis et al. [IJTAHC 19:3(2003)] was used to
assign HRQOL scores (MDS items were mapped to the Health Utilities Index Mark 2 (HUI2) scoring function to
create the MDS-HSI score). Anemia was defined as Hb <12 g/dL females and <13 g/dL males. Adjusted linear
regression was used to evaluate the independent association of anemia and hemoglobin level on MDS-ADL and
MDS-HSI scores.
Results: 838 residents met all inclusion criteria; 46% of residents were anemic. Mean (SD) MDS-ADL score was 14.9
(7.5) [0–28 scale, where higher score indicates worse functioning]. In the adjusted model, anemia was associated
with a significantly worse MDS-ADL score (+1.62 points, P=.001). Residents with Hb levels 10 to <11 g/dL had
significantly worse ADL score (+2.06 points, P=.005) than the >13 g/dL reference. The mean MDS-HSI score was
0.431 (0.169) [range, where 0=dead to 1=perfect health]. Compared with non-anemic residents, in this adjusted
model, residents with anemia had significantly worse MDS-HSI scores (−0.034 points, P=.005). Residents with
hemoglobin levels <10 g/dL had significantly worse MDS-HSI scores (−0.058 points, P=.016) than the >13 g/dL
reference.
Conclusions: After adjusting for several covariates, LTC residents with anemia, and many of those with moderate to
severe declines in Hb level, had significantly poorer outcomes in both ADL functioning and HRQOL. The association
between Hb level and the HRQOL measure of MDS-HSI appears to be largely explained by the mobility domain of
the HRQOL measure.
Keywords: Anemia, Long-term care, Activities of daily living, Quality of life, Health status* Correspondence: greardon@informagenics.com
2Informagenics, LLC & The Ohio State University College of Pharmacy,
Columbus, OH, USA
5450 W. Wilson Bridge Rd., Suite 340, Worthington, OH 43085, USA
Full list of author information is available at the end of the article
© 2012 Bailey et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Bailey et al. Health and Quality of Life Outcomes 2012, 10:129 Page 2 of 11
http://www.hqlo.com/content/10/1/129Background
The prevalence of anemia is high among residents of
long-term care (LTC) facilities [1]. Using the WHO def-
inition [2] (hemoglobin [Hb] <12 g/dL for females and
<13 g/dL for males) to define anemia status, the preva-
lence rate reported in five LTC studies has ranged from
40% to 60% [3-7].
Adverse clinical outcomes have been associated with
anemia in the LTC setting. In studies that have included
LTC residents, anemia has been linked to higher rates of
falls [3,8,9] and hospitalizations [9,10]. Anemia in LTC
residents has also been associated with a 17% higher risk
of 1-year mortality (though not independently of activ-
ities of daily living (ADL) performance) [11], with a 60%
higher risk of mortality among residents who later
experienced a hip fracture [12], and with twice the risk
of mortality in female residents [13].
Balducci et al. [14] hypothesize that elderly people
generally have a reduced capacity to cope with illness,
and therefore, in this population, health-related quality
of life (HRQOL) and functional ability may be affected
by declining health and anemia. In the elderly, anemia
has been linked to deficits in physical performance
[15-20], including functional decline in activities of daily
living (ADL), though only one study has evaluated this
association in the LTC setting. In a retrospective review
of Minimum Data Set (MDS) assessments among 24 U.S.
LTC facilities, Schnelle et al. found that anemic residents
with chronic kidney disease (CKD) had significantly worse
performance than non-anemic CKD residents on seven
of ten individual ADL items [21].
Studies of older patients have also demonstrated sig-
nificant associations between anemia [22-24] and
HRQOL, though only one study has evaluated this asso-
ciation in LTC. In a study of LTC residents in Ontario,
Lam et al. [25] found that anemia had a significant im-
pact on HRQOL score, when applying an adjusted
model that included 60 diseases that were also tested.
Given the high prevalence of anemia in LTC and its
observed associations with specific clinical events, the
current study evaluates in LTC residents the association of
anemia and Hb level with a physical functioning index,
the Carpenter et al. ADL score [26], and with an HRQOL
index, the Minimum Data Set Health-Status Index (MDS-
HSI) [27]. Both assessment measures are derived from the
MDS, a comprehensive and longitudinal clinical assess-
ment of LTC residents that is routinely collected in the
U.S., Canada, and in more than 20 countries [26].
Methods
Study design
This study used a retrospective cross-sectional design.
Data was obtained from the AnalytiCare LTC database
for residents of 27 LTC facilities in the state of Coloradothat contributed Minimum Data Set (MDS) version 2.0,
laboratory records and pharmacy dispensing records to
this integrated database. Although the MDS is a compo-
nent of the medical chart in LTC facilities, data collected
in this instrument may not capture all comorbid condi-
tions noted elsewhere in the chart. The MDS 2.0 has
been reported to have moderate to moderate/high valid-
ity and reliability, but may underreport some conditions
such as depression [28]. Wodchis et al. reported sensitiv-
ities exceeding 0.60-0.80 for 22 common diagnoses, but
also noted limitations in capturing several conditions
[29]. Electronic MDS, laboratory and pharmacy records
were complete for all included study residents, though
use was not captured of over-the-counter medications
not otherwise dispensed by LTC pharmacies. All data
used in this study was de-identified, HIPAA compliant,
and exempt from requirement for IRB review.
Data elements were collected for residents during the
study timeframe of 1/1/07-9/15/08. To be included in
this study, residents were required to have: 1) complete
MDS, pharmacy and lab data available in the AnalytiCare
database and at least one non-admission/non-discharge
MDS assessment performed during the study time-
frame, 2) residence in the LTC facility for more than
90 days (i.e. were not newly admitted to the LTC facility),
3) a hemoglobin (Hb) and serum creatinine (sCr) lab
value within 90 days of the earliest non-admission MDS,
and 4) documented age, gender, and race. The earliest
periodic MDS assessment available during the study
timeframe was identified as the index MDS. Residents
were excluded from analysis if, on the index MDS, they
were identified either to have a diagnosis of cancer, were
receiving chemotherapy, were receiving renal dialysis,
had end-stage renal disease, had a life expectancy of less
than 6 months or were receiving hospice care.
Anemia status and covariates
Anemia status was based solely on the Hb value (index
Hb) of the lab test performed closest to, and within 90
days, of the index MDS date. Anemia status was defined
using the World Health Organization definition [2]
(where anemia occurs if Hb <12 g/dL for females and
<13 for males). An alternative to anemia status,
hemoglobin range, was estimated for each resident by
assigning the index Hb to one of five values: ≥13 g/dL,
12 to <13, 11 to <12, 10 to <11, <10 [9]. Estimation of
CKD, a covariate in the analysis, was identified from lab
or MDS evidence if, from the sCr closest to and within
90 days of the MDS, the resident had either estimated
GFR <60 mL/min/1.73 m2 (Modification of Diet in Renal
Disease equation version 4) [30], or if the resident had
renal failure checked on the index MDS Section I1, or
else had an entry for chronic kidney disease recorded
in MDS Section I3 Other Current of More Detailed
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classes (also used as covariates in the analysis) were based
on evaluation of all prescriptions dispensed 30 days prior
to and 90 days after the index Hb. All other model cov-
ariates and the ADL and HRQOL endpoint measures
were derived from the index MDS.
MDS-ADL score
The ADL self-performance ratings in section G of the
MDS version 2.0 have been used to evaluate physical
functioning in the LTC facility [26,31]. Carpenter et al.
[26] developed a method for estimating ADL perform-
ance in the LTC facility by summing the self-
performance ratings for seven items in the MDS: bed
mobility, transfer, locomotion, dressing, eating, toilet use
and personal hygiene. Each item is rated by the LTC co-
ordinator on a scale from 0 (independent) to 4 (total de-
pendence). Alternatively, the coordinator is permitted to
assign a value of “activity did not occur during the entire
7 days” to any ADL assessment item. Here, following
Carpenter et al. [26] we assigned a substitute rating of 4
(total dependence) by assuming that the resident was in-
capable of self-performance on this ADL item during
the seven-day recall period for this section. We then
summed, for each resident, the value of the numeric rat-
ing for all seven items, calculating the total MDS-ADLa
performance score ranging from 0 (completely inde-
pendent) to 28 (completely dependent). Thus a higher
MDS-ADL score indicates worse ADL performance.
MDS-HSI score
The HRQOLb score was calculated by using the MDS-
HSI methodology developed by Wodchis et al [27].
These authors developed this method as a practical
means of mapping selected items from the standard
MDS assessments conducted in LTC facilities and home
care settings to an established measure of HRQOL, the
Health Utilities Index Mark 2 [HUI2] [32,33]. The result
of this approach yields both an overall HRQOL score,
the MDS-HSI, and individual subscores for the six
dimensions comprising the HUI2: sensation, mobility,
emotion, cognition, self-care, and pain.
Wodchis et al. [27] selected the HUI2 as the basis for
the MDS-HSI score, rather than the newer HUI3 instru-
ment, since the HUI2 permits a focus on self-care, consid-
ers pain in the context of analgesics to manage it, and
places emotion in the context of worry and anxiety rather
than happiness vs. depression. The HUI instruments have
been administered as both self- and proxy-assessments
(e.g. by a spouse or healthcare professional on behalf of
the responsible individual) [33]. In their original work,
Wodchis et al. [27] found preliminary evidence of con-
vergent and construct validity for the MDS-HSI by first,
comparing single-attribute scores from the MDS-HSIwith summated scales based on the same attributes,
and secondly by separately comparing MDS-HSI scores
between residents of supportive housing, recipients of
home care services in the community, LTC residents,
and patients in a chronic care hospital with HUI2
scores obtained separately from an external reference
population (1996 National Population and Health Sur-
vey) of community- and institutional-based respondents.
A later study [34] assessed criterion validity of the
MDS-HSI in a nursing home population against scores
derived from interviewer-administered HUI2 in study
residents. Wodchis et al. found analogous group-level
concordance, but only moderate individual-level agree-
ment. These authors concluded that the MDS-HSI can
be used to substitute for the HUI2 in group-level com-
parisons but not for individual clinical evaluation com-
parisons [34].
Following the MDS-HSI to HUI2 mapping algorithm
reported by Wodchis et al. [27], we calculated, from the
index MDS, for each study resident a summary MDS-
HSI score and individual subscores for the six MDS-HSI
dimensions. The summary score is interpreted such that
a value of 1 represents the preference assigned perfect
health, while a value of 0 represents dead.Statistical analysis
Stata (Intercooled 8.0, College Station TX) was used to
conduct statistical analysis. Unadjusted estimates of MDS-
ADL and MDS-HSI scores were compared through cross
tabulation with both anemia status and hemoglobin range.
Multiple regression, adjusted for covariates potentially
related to the study endpoints (demographics, renal func-
tion, falling history, conditions; a full listing of covariates
is shown in Tables 1 and 2), was conducted to separately
evaluate the potential independent effect of 1) anemia
status, and 2) Hb range, on the study endpoints of MDS-
ADL and MDS-HSI scores. Starting with the large set of
covariates, backward elimination was used to efficiently
reduce the final set of retained covariates, retaining those
covariates with P≤0.25 through each successive iteration
of the model. Since the WHO definition of anemia incor-
porates gender with Hb to determine anemia status, the
interaction term of gender with anemia status was added
to the anemia models.Results
Of the 1,460 residents who satisfied inclusion rules,
622 who met also met one or more exclusion rules,
thus leaving 838 eligible residents for analysis. Summary
statistics are shown in Table 1 (demographics and
hemoglobin) and Table 2 (conditions). The median resi-
dent age was 82 years (resident ages in the study database
were truncated at 90 years due to HIPAA safe-harbor
Table 1 Resident demographics and hemoglobin





Median [interquartile range] 81 [71–88] 82 [72–88] - 82 [72–88]
≤65 17% 15% 0.627 16%
65-74 13% 15% 14%
75-84 31% 31% 31%
85+ 39% 39% 39%
Female 74% 59% <0.001 67%
Race/Ethnicity
White, not of Hispanic Origin 81% 82% 0.472 82%
Black, not of Hispanic Origin 4% 5% 5%
Asian/Pacific Islander 2% 1% 2%
Hispanic 12% 12% 12%
Am Indian/Alaskan Native 0% 0% 0%
Other 0% 0% 0%
Educational Level
Less than 12 years 18% 23% 0.260 20%
High school graduate 39% 34% 37%
Some college 14% 17% 15%
College graduate 10% 10% 10%
Unknown 19% 17% 18%
Hemoglobin
Mean (SD) Hemoglobin Level (g/dL) 13.6 (1.1) 10.9 (1.0) <0.001 12.4 (1.7)
Anemic (from index Hb, WHO definition)* 0% 100% <0.001 46%
Hemoglobin Level ≥13 g/dL 68% 0% <0.001 37%
Hemoglobin Level 12 to <13 32% 12% 23%
Hemoglobin Level 11 to <12 0% 41% 19%
Hemoglobin Level 10 to <11 0% 31% 14%
Hemoglobin Level <10 0% 16% 8%
Terms: WHO, World Health Organization.
* WHO definition of anemia = index Hb <12 g/dL if female, <13 g/dL if male.
† F-tests used for differences in means; Chi-square tests used for proportions.
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anemic and non-anemic groups. Index Hb levels were
lower on average by 2.7 g/dL for the 46% of residents
with lab-defined anemia than for the 54% who did not
have anemia (P<.001). A lower proportion of anemic resi-
dents (59%) were female compared with non-anemic
ones (74%, P<.001, Chi-square). The distribution of race/
ethnicity categories was similar among anemic and non-
anemic groups. Distribution by Hb range revealed that
approximately 40% of all residents had Hb levels below
12 g/dL (Table 1).
Of the 838 study residents, all had complete data for
the seven self-performance MDS items required tocalculate an MDS-ADL score and were included in the
ADL analysis. Unadjusted analysis revealed that the
mean (SD) MDS-ADL score for all study residents was
14.9 (7.5) [of 0 to 28 possible range where a lower score
means better ADL performance]. Mean (SD) MDS-ADL
score for the non-anemic population was 14.3 (8.0) and
for the anemic population was 15.5 (6.8) [P=.014, t-test].
Table 3 shows findings from the adjusted regression
model for anemia status and MDS-ADL score. Anemia
was associated with a 1.62 worse ADL score when com-
pared with the non-anemic reference case (P=.001). Of
the covariates retained within the model, a significantly
poorer MDS-ADL score was seen, in descending order
Table 2 Resident conditions




Section I CKD or GFR Stage 3-5 37% 52% <0.001 44%
Falling History
Fell in Past 30 or 180 Days 45% 48% 0.377 47%
Diseases and Conditions
Alzheimer's disease 9% 3% 0.002 6%
Arteriosclerotic heart disease 2% 6% 0.009 4%
Arthritis 11% 10% 0.713 10%
Asthma 2% 2% 0.889 2%
Bone Fracture (Pathological) 2% 4% 0.114 3%
Cerebral Palsy 0% 0% 0.355 0%
Cerebrovascular Accident 15% 16% 0.762 15%
Congestive Heart Failure 10% 14% 0.089 12%
Emphysema/COPD 7% 15% <0.001 10%
Dementia (not Alzheimer's) 23% 24% 0.769 24%
Deep Vein Thrombosis 1% 2% 0.149 1%
Diabetes Mellitus 25% 37% <0.001 30%
Hemiplegia/hemiparesis 6% 5% 0.332 5%
Hip Fracture 2% 5% 0.004 3%
Hypotension 4% 2% 0.098 3%
Missing Limb 1% 1% 0.846 1%
Multiple Sclerosis 4% 2% 0.051 3%
Osteoporosis 7% 7% 0.962 7%
Peripheral Vascular Disease 4% 4% 0.649 4%
Paraplegia 0% 1% 0.874 0%
Parkinson's Disease 1% 1% 0.566 1%
Quadriplegia 1% 1% 0.349 1%
Seizure Disorder 6% 3% 0.134 5%
Transient Ischemic Attack 1% 1% 0.864 1%
Current Medications
Antianxiety/Hynotic/ Antipsychotic 82% 80% 0.625 81%
Antidepressant 67% 67% 0.898 67%
Beta Blocker 27% 43% <0.001 35%
Diuretic 41% 49% 0.023 45%
All values were obtained from the index MDS, index hemoglobin, serum creatinine or the pharmacy database (with fill dates 30 days prior to 90 days after the
index hemoglobin). †Chi-square tests used for proportions.
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sclerosis, age 85+, Asian/Pacific islander, age 75–84,
hemiplegia, age 65–74, cerebral vascular accident,
Alzheimer’s disease, female, tech school/some college
education, fell within 180 days prior to the index MDS,
and Section I CKD or GFR Stage 3–5. The latter had a
negative association with poorer MDS-ADL score.
Table 4 shows findings from the sensitivity analysis for
the MDS-ADL and MDS-HSI adjusted regressionmodels, where Hb range is substituted for anemia status,
and the interaction term of anemia with gender is
removed. For the MDS-ADL, when compared with the
reference range of Hb ≥13 g/dL, residents with Hb levels
11 to <12 (+0.85 points, P=.184), 10 to <11 (+2.06
points, P=.005) and <10 (+1.79 points, P=.059) had
worse MDS-ADL scores, though only the difference for
Hb 10 to <11 was significant. A coefficient for Hb level
12 to <13 is not shown in Table 4 since this Hb level
Table 3 Regression model for anemia status and MDS-ADL score
Coefficient 95% Lower bound 95% Upper bound p-value
Anemic (Index Hb) 1.62 0.63 2.62 0.001
Female 1.66 0.60 2.71 0.002
Age 65-74 2.94 1.17 4.72 0.001
Age 75-84 4.00 2.41 5.58 <0.001
Age 85+ 4.57 2.96 6.18 <0.001
Black, not of Hispanic Origin 2.18 −0.17 4.53 0.069
Asian/Pacific Islander 4.01 0.27 7.75 0.036
Tech School or Some College 1.50 0.16 2.84 0.029
College Grad or Advanced Degree 1.45 −0.15 3.04 0.075
Section I CKD or GFR Stage 3-5 −1.20 −2.22 −0.18 0.022
Fell in Past 180 Days 1.30 0.34 2.26 0.008
Alzheimer's Disease 2.52 0.52 4.51 0.014
Bone Fracture 2.03 −0.66 4.71 0.139
Cerebral Palsy 18.87 5.06 32.68 0.007
Cerebral Vascular Accident 2.65 1.18 4.13 <0.001
COPD 1.43 −0.16 3.02 0.078
Diabetes Mellitus 0.75 −0.33 1.84 0.174
Hemiplegia 3.78 1.45 6.12 0.002
Multiple Sclerosis 7.54 4.51 10.56 <0.001
Parkinson's Disease 3.65 −0.99 8.30 0.123
Quadriplegia 9.90 4.92 14.87 <0.001
Seizure 1.78 −0.58 4.13 0.139
Transient Ischemic Attack −4.06 −9.35 1.23 0.132
Antianxiety/Hynotic/Antipsychotic Med −1.28 −2.96 0.41 0.138
Antidepressant Medication 0.85 −0.55 2.25 0.234
Intercept 7.78 5.82 9.75 <0.001
MDS-ADL Score (0–28 where higher score is worse score). Reference is not anemic, male, age <65 years, white race, not completed high school, GFR stage 1–2
(from serum creatinine) or no MDS Section I CKD noted, not fallen in past 180 days, absence of conditions or drugs listed. n=838. Adjusted r2=0.1454.
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wards selection process, having a P-value exceeding 0.25.
For estimation of MDS-HSI scores, 777 of the 838
retained residents had non-missing data for all MDS ele-
ments required to calculate a summary MDS-HSI scoreTable 4 Sensitivity analysis: Regression models for hemoglob
Coefficient 95
MDS-ADL score
Hemoglobin Level 11 to <12 g/dL 0.85
Hemoglobin Level 10 to <11 2.06
Hemoglobin Level <10 1.79
MDS-HSI score
Hemoglobin Level 12 to <13 g/dL −0.026
Hemoglobin Level 11 to <12 −0.021
Hemoglobin Level 10 to <11 −0.031
Hemoglobin Level <10 −0.058
MDS-ADL Score (0–28 where higher score is worse score). MDS-HSI Score where 0=
these adjusted models show only estimates for hemoglobin ranges in this table, an
elimination (P<0.25).and were included in the MDS-HSI analysis. In this
unadjusted analysis, mean (SD) MDS-HSI score for all
study residents was 0.431 (0.169) [of 0 to 1 possible range
where a higher score means a better HRQOL]. Mean
(SD) MDS-HSI score for the non-anemic population wasin range with MDS-ADL score and MDS-HSI score








dead and 1=perfect health. Reference is hemoglobin ≥13 g/dL. Findings from
d only for those ranges that were retained in the final models after backwards
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(0.161) [P=.048, t-test]. Figure 1 shows the distribution of
both the mean MDS-HSI summary scores for each of the
five categories of Hb range, as well as the mean individ-
ual domain scores.
In the adjusted regression model for MDS-HSI score
(Table 5) having anemia was associated with a 0.034
lower or worse MDS-HSI score when compared with
the non-anemic reference case (P=.005). Of the covari-
ates retained within the model, a significantly worse
MDS-HSI summary score was seen, in descending
order of association with quadriplegia, multiple scler-
osis, Asian/Pacific Islander, age 65–74, Alzheimer's dis-
ease, age 85+, age 75–84, hemiplegia, fell within 180
days prior to the index MDS, tech school/some college
education, and female.
Table 4 shows findings of the sensitivity analysis for
MDS-HSI adjusted regression model, where Hb range is
substituted for anemia status, and the interaction term
of anemia with gender is removed. Compared with the
reference range of Hb ≥13 g/dL, the MDS-HSI summary
score was worse for Hb 12 to <13 (−0.026 points,
P=.101), 11 to <12 (−0.021 points, P=.209), 10 to <11
(−0.031 points, P=.099), and <10 (−0.058 points,
P=0.016). Only the finding for Hb <10 g/dL was signifi-
cant. Since four regression models were evaluated in this
analysis (anemia with MDS-ADL, anemia with MDS-HSI,
Hb range with MDS-ADL, Hb range with MDS-HSI) the
familywise error rate was maintained as a further sensi-
tivity test by recalculating the individual test type I error
rate to α/n = 0.0125. In this case, significant findings
for the anemia and Hb range associations were main-
tained, but with the exception of the significant MDS-
HSI finding for Hb <10 g/dL (P=0.016), which exceeded
this threshold.
Discussion
In the past, anemia was viewed as a sign of underlying
disease, while today this condition is considered by many



















Sensation Mobility Emotion Cognition
Domain
S
*For summary score, 0-1 scale where 0 = dead and 1 = perfect hea
Figure 1 Mean MDS-HSI score by hemoglobin range.life, morbidity, decline in physical function, and a risk
factor for death [14]. Within the specific context of man-
aging anemia in the elderly patient, Balducci [35] identi-
fies the “compression of morbidity” as one of the most
worthwhile goals of geriatric medicine. Here the goal of
the clinician is to delay and reverse the manifestations of
aging to improve function, quality of life, and overall
well-being of the geriatric patient. Thomas [36] offers
similar support for including functioning and quality
endpoints in geriatrics, concluding that there is a direct
and independent effect of hemoglobin concentration on
the symptom scores used to assess quality of life in a
number of disease conditions: “The data suggest that we
may not be able to modify the course of chronic kidney
disease or other chronic diseases, but we do have the
capacity to ameliorate the symptom complex that fre-
quently is associated with anemia” [36].
Anemia and ADL
Performance indicators such as ADL may be relevant
predictors of physiologic outcomes in their own right.
Abicht-Swensen et al. [37] observed in LTC residents
that ADL, as calculated from the MDS, was a strong in-
dependent predictor of short-term mortality. Van Dijk
et al. [11] found that when ratings for four items in the
ADL section of the MDS were added to an adjusted
model, that ADL was significantly associated with mor-
tality within the first year of an MDS assessment. This
association was independent of anemia and other resi-
dent factors.
In the current study the mean MDS-ADL score was
15.5 for the anemic residents and 14.3 for non-anemic
residents. This compares with a mean score of 14.8
among mildly cognitively impaired residents and a wor-
sened 19.0 mean score among severely cognitively
impaired residents within a single U.S. nursing home
reported in Carpenter et al.’s original work on the MDS-
ADL [26]. Regarding the potential association between
anemia and poorer physical functioning, the evidence




Hb 10 to <11
Hb 11 to <12
Hb 12 to <13
Hb 13+ g/dL
Table 5 Regression model for anemia status and MDS-HSI score
Coefficient 95% Lower bound 95% Upper bound p-value
Anemic (Index Hb) −0.034 −0.057 −0.010 0.005
Female −0.027 −0.052 −0.002 0.037
Age 65-74 −0.090 −0.133 −0.048 <0.001
Age 75-84 −0.065 −0.103 −0.028 0.001
Age 85+ −0.084 −0.122 −0.047 <0.001
Black, not of Hispanic Origin −0.047 −0.103 0.008 0.096
Asian/Pacific Islander −0.099 −0.195 −0.003 0.044
Tech School or Some College −0.037 −0.068 −0.006 0.021
Section I CKD or GFR Stage 3-5 0.018 −0.006 0.042 0.142
Fell in Past 180 Days −0.051 −0.074 −0.028 <0.001
Alzheimer's Disease −0.094 −0.142 −0.047 <0.001
Bone Fracture −0.058 −0.120 0.003 0.064
Cerebral Palsy −0.244 −0.562 0.074 0.133
Cerebral Vascular Accident −0.026 −0.060 0.009 0.145
Hemiplegia −0.063 −0.119 −0.007 0.026
Multiple Sclerosis −0.122 −0.193 −0.051 0.001
Parkinson's Disease −0.094 −0.199 0.011 0.081
Quadriplegia −0.191 −0.306 −0.077 0.001
Seizure −0.044 −0.100 0.011 0.119
Antidepressant Medication −0.015 −0.040 0.009 0.221
Intercept 0.589 0.549 0.630 <0.001
MDS-HSI Score where 0=dead and 1=perfect health. Reference is not anemic, male, age <65 years, white race, not completed high school, GFR stage 1–2 (from
serum creatinine) or no MDS Section I CKD noted, not fallen in past 180 days, absence of conditions or drugs listed. n=777. Adjusted r2=0.1155.
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was significantly worse for anemic residents. After
adjusting for potential confounders in the regression
model, we found that anemia was independently asso-
ciated with greater impairment of MDS-ADL perform-
ance. In the adjusted sensitivity analysis substituting Hb
range for anemia status, we found that only the moder-
ately severe anemia range of 10 to <11 g/dL had a sig-
nificantly lower MDS-ADL score when compared with
the >13 g/dL reference. The next lowest Hb range of
<10 g/dL had a regression coefficient that was similar to
the 10 to <11 g/dL range, but the former was not signifi-
cant since many fewer residents had this severely low
value (Table 1).
As described above, Schnelle et al. found in an un-
adjusted analysis of single-item ADL ratings, that anemic
LTC residents with CKD had significantly worse per-
formance than non-anemic CKD residents on every
ADL item except for “locomotion off unit,” “eating” and
“personal hygiene.” [21] Earlier studies have consistently
reported an association between anemia and ADL func-
tion for older persons in the community [15-20].
Anemia and HRQOL
The mean MDS-HSI score was 0.418 for the anemic
cohort (0.411 for females, 0.428 for males) and 0.442for non-anemic one (0.430 for females, 0.474 for
males). Two studies of residents at hospital-based LTC
facilities in Ontario have reported substantially lower
MDS-HSI scores (0.31 for females, 0.38 for males) [27]
and (0.293 for females, 0.286 for males) [25] The
somewhat lower MDS-HSI scores found in these earl-
ier LTC studies might be due to high levels of medical
impairment noted among these hospital-based cohorts,
though MDS-HSI scores from both the current and
these earlier LTC studies were both far lower than
comparable HUI2 normative scores for the U.S.
community population of 0.85 (65–74 years) and 0.83
(75–89 years).
Findings from the current study suggest that there is
an association between anemia and impaired quality of
life. In the unadjusted analysis in the current study, the
mean MDS-HSI summary score was significantly worse
for anemic residents. Of the six domains comprising the
MDS-HSI summary score, Figure 1 shows that declines
in mobility with decreasing Hb level appear to explain
much of this difference in quality-of-life assessment be-
tween anemic and non-anemic residents. We found, in
our adjusted analysis, that anemia was independently
associated with a worse MDS-HSI score. In the adjusted
sensitivity analysis substituting Hb range for anemia
status, we found that only the severe anemia range of
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when compared with the >13 g/dL reference.
Several earlier studies have evaluated the association
between quality-of-life measures and anemia. As
described above, Lam et al. found that anemia had a sig-
nificant association with HRQOL in the LTC setting
[25]. That study assessed HRQOL with the same MDS-
HSI measure used in the current study, though in a dif-
ferent LTC population (hospital-based LTC facility in
Ontario) and utilizing a different regression modeling
approach (full model retaining 60 disease predictors). In
that study anemia was significantly associated with only
0.022 unadjusted and 0.006 lower adjusted MDS-HSI
score vs. the significantly lower scores of 0.024 (un-
adjusted) and 0.034 (adjusted) that we found in the
current study of a pool of U.S. nursing homes and utiliz-
ing a stepwise regression model. Studies outside of the
LTC setting have also reported an association of anemia
with HRQOL in older patients [22-24].Evaluating clinically-meaningful difference
In the current study, the independent effect of anemia
was a 1.62 point worse adjusted MDS-ADL score. Find-
ings from this study also showed that anemia was asso-
ciated with a 0.034 adjusted lower MDS-HSI summary
score. When modeling relationships between a condition
such as anemia and worsened performance on humanis-
tic measures at a single point in time, one concern is in-
terpretation of the meaning of such differences. A
limitation of the current study is that one can only
speculate regarding such meaning; meaningful differ-
ences are not formally assessed in such between-group
models [38-40]. Minimally-important individual change
differences have been assessed, but the latter are not dir-
ectly comparable to between-group model effects. For
instance, Carpenter et al. evaluated changes in the MDS-
ADL within individuals and concluded that ”[a] change
of one point in the MDS-ADL scale denotes a clinically
meaningful change.” A difference of 0.03 for the Health
Utilities Index (HUI) instruments has been identified by
Drummond [41] and Grootendorst et al. [42] as a
clinically-important change. Drummond [41] has stated
that a difference as low as 0.01 may be may be meaning-
ful and important in some settings.Limitations
This study has several additional limitations. First, even
though the LTC facility coordinator conducting the MDS
assessment is directed to observe and communicate with
the resident when completing the assessment, data is gath-
ered from multiple sources [43], thus assessments of
MDS-ADL and MDS-HSI are largely by proxy, rather
than by self-report, and so are dependent on the quality ofthese data sources. Second, although the MDS prompts
the LTC facility coordinator to report, in detail, diseases
and conditions currently experienced by the resident
(either through checkbox or open-ended entry of condi-
tions), underreporting of such diseases and conditions on
the MDS has been known to occur [44]. However, other
studies have found high inter-rater reliability of quality
indicators and strong correlations with independent obser-
vation of residents [45,46]. Third, potential confounders
with anemia in the adjusted regression models we were
limited to only those data elements contained in the MDS,
pharmacy fills or index lab values. Other relevant factors
potentially related to the clinical endpoints studied may
not have been included in this study. Fourth, the regres-
sion models only tested a linear association between
anemia/hemoglobin range and the outcomes of MDS-
ADL and MDS-HSI score. Non-linear regression models
(e.g. quantile regression) or transformations of these
scores might have revealed different findings. Finally,
anemia status was determined by a single index Hb value,
so we were unable to determine whether the anemia status
was an acute or chronic state, what the cause of the
anemia was, and whether the MDS-ADL and MDS-HSI
assessments changed over time within residents as anemia
status and Hb levels changed.Conclusions
After adjusting for several covariates, LTC residents who
had anemia, and many of those who had moderate to se-
vere declines from normal Hb levels, had significantly
poorer outcomes in ADL functioning (MDS-ADL) and
HRQOL (MDS-HSI). The association between Hb level
and MDS-HSI is largely influenced by the relationship of
Hb level with the mobility domain of this measure.
For the geriatric clinician, goals for managing anemia
should include therapeutic efforts to improve hemoglobin
levels among those who are severely anemic. Separate
from this, a focus on improving related symptom com-
plexes, including fatigue, lack of energy and functional
capacity may itself directly benefit anemic patients [36].
Summary QOL and ADL scores, such as the ones evalu-
ated here, can be readily electronically calculated for each
resident from existing electronic MDS forms, which are
completed at least once quarterly. Following the original
intent of those researchers who designed or adapted these
scoring algorithms [26,27] the MDS-ADL and MDS-QOL
may find a role as meaningful, longitudinal clinical out-
comes for other serious conditions besides anemia.
Further research is needed to test the association
between changes in anemia status or Hb level against
changes in MDS-ADL and MDS-HSI scores, longitu-
dinally, within the same residents. Further research is
also needed to further test and potentially improve the
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LTC, including validation of the newly-introduced MDS
version 3.0. For the MDS-ADL, research should test
this measure against external instruments that object-
ively assess functional performance. Further research
should also test the MDS-HSI against alternative mea-
sures of HRQOL applied to the same residents, and to
assess content and construct validation of the MDS-
HSI domains of sensation, mobility, emotion, cognition,
self-care, and pain as adequate representation of
HRQOL in LTC residents.Endnotes
aCarpenter et al. did not assign a name to their sum-
mary ADL measure. We introduce the term “MDS-ADL”
here.
bAlthough some researchers regard health status and
HRQOL as separate constructs, these terms are used
interchangeably in the original work of Torrance et al.
[Torrance GW, Feeny DH, Furlong WJ, Barr RD, Zhang Y,
Wang Q. Multiattribute utility function for a comprehen-
sive health status classification system. Health Utilities
Index Mark 2. Med Care. Jul 1996;34(7):702–722].
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